Log In
Print
BCIQ
Print
Print this Print this
 

TH-302

  Manage Alerts
Collapse Summary General Information
Company Threshold Pharmaceuticals Inc.
DescriptionHypoxia-activated cytotoxic 2-nitroimidazole prodrug of the DNA alkylator bromoisophosphoramide mustard (Br-IPM)
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today